During the past decade, Orkdal Sykehus conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orkdal Sykehus" #1 collaborator was "Helse Midt-Norge" with 2 trials as a collaborator and "St. Olavs Hospital" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Orkdal Sykehus" are "Stroke" (2 trials), "Brain Ischemia" (1 trials), "Cardiovascular Diseases" (1 trials), "Cardiovascular Risk Factor" (1 trials) and "Central Nervous System Lymphoma" (1 trials). Many other conditions were trialed in "Orkdal Sykehus" in a lesser frequency.

Most popular intervention types in "Orkdal Sykehus" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orkdal Sykehus" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Orkdal Sykehus". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orkdal Sykehus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orkdal Sykehus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".